1. Market Research
  2. > Healthcare Market Trends
  3. > FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (EU5)

FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (EU5)

  • March 2015
  • -
  • Firstword Pharma

Summary

Table of Contents




FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (US) provides cutting edge, advanced and proprietary analytics that companies operating in the MS space need to develop, shape and refine brand strategy.

Critically, the report quantifies the impact and influence of specific environmental barriers – such as price, availability and reimbursement – in relation to how much market share your brand gains and loses, to which brands your share is going to, and from which brands your brand is getting share from.

The proprietary barrier instrument utilizes statistical analysis and advanced calculation to provide you with this precise information. This information allows you to act strategically and focus on the market barriers that can drive market share gains and improve competitiveness for your brand.







Key Issues Expored

Each brand's current user base, plus doctors who are not current users but would consider using it
In the market, the percentage of prescriptions influenced by barriers, the barriers experienced and the volume of prescriptions these barriers represent
Amount of share each brand gains/loses due to the barriers

Get Answers to Critical Questions

What brands are physicians across the major markets of Europe – France, Germany, Italy, Spain, the UK prescribing to their MS patients?

What is the top market barrier that forces a physician to prescribe a drug they didn’t intend to?

Which MS drug gains the most and least share due to current market barriers?
Which MS drug is benefiting the most from current market barriers?
What are the most common barriers in the US that cause a brand to gain and lose market share?



MS Brands Reviewed

Avonex (interferon-beta-1a)
Rebif (interferon-beta-1a)
Betaseron (interferon-beta-1b)
Extavia (interferon-beta-1b)
Copaxone (glatiramer acetate; including daily and 3x weekly formulations)
Gilenya (fingolimod)
Tecfidera (dimethyl fumarate)
Aubagio (teriflunomide)
Tysabri (natalizumab)


Methodology


Sample Distribution
150 neurologists in the France, Italy, Spain, Germany and the UK.

Interviewing Methodology
Data collected via a 10-minute questionnaire.

Screening Criteria
See at least 2 relapsing/remitting MS patients in past month
Have been in active practice 2+ years
Prescribed at least one of the listed products

About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. FirstWord Reports provide expert views and intelligence on the challenges facing pharma today in these topic areas: Biosimilars, Market Access, Medical Affairs, Sales & Marketing, Technology, Therapy Areas.
FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.

Learn more at www.firstwordgroup.com.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...


Download Unlimited Documents from Trusted Public Sources

Hospital Industry in the UK

  • April 2017
    183 pages
  • Hospital  

    Intensive Care  

    Health Care Pro...  

  • United Kingdom  

View report >

Depression Statistics in the Netherlands

  • April 2017
    219 pages
  • Depression  

    Occupational He...  

  • Netherlands  

View report >

Occupational Health Industry in the Netherlands

  • April 2017
    27 pages
  • Occupational He...  

  • Netherlands  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.